Sort
261,768 grants matching “gene therapy”
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity
$846,940Douglas Kwon · Massachusetts General Hospital · R01 · FY2021 · DK
Multi-omics characterization of HIV-associated changes in the gut microbiome and host mucosal immunity
$846,940Douglas Kwon · Massachusetts General Hospital · R01 · FY2022 · DK
Genomic approach to identification of microglial networks involved in Alzheimerâs disease risk
$846,895Alison M Goate · Icahn School Of Medicine At Mount Sinai · U01 · FY2018 · AG
Optimizing the graft versus leukemia effect for pediatric ALL
$846,887Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Research Project I - Vesicant-Induced Skin Injury
$846,767Donald R Gerecke · Rbhs-School Of Public Health · U54 · FY2020 · AR
Research Project I - Vesicant-Induced Skin Injury
$846,767Donald R Gerecke · Rbhs-School Of Public Health · U54 · FY2019 · AR
Research Project I - Vesicant-Induced Skin Injury
$846,767Donald R Gerecke · Rbhs-Robert Wood Johnson Medical School · U54 · FY2016 · AR
Signal Transduction Events and the Regulation of Cell Growth
$846,744Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA
Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
$846,735Levi Waldron · Graduate School Of Public Health And Health Policy · U24 · FY2024 · CA
Determining the Fate of Transmembrane Proteins
$846,720Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Development of a companion diagnostic to identify patients who respond to microbiome-targeting drugs
$846,715Bret David Wallace · Symberix, Inc. · R44 · FY2021 · GM
Defining the Mechanisms of Immune Escape After Adoptive T cell Therapies
$846,699Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development.
$846,678Magali Soumillon · Flexomics Llc · R44 · FY2023 · CA
Cellular Interactions with Thrombospondin
$846,593David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
$846,498Joshua Tisdell Schiffer · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
Clinical trials employing cancer vaccine combination therapies
$846,484James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$846,484James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts
$846,454Stephen J O'Brien · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Characterization of Persistent COVID-19
$846,387Jonathan Li · Brigham And Women'S Hospital · R01 · FY2024 · AI
Intragraft expression to Predict Future GFR Decline in Kidney Transplantation
$846,386Mark D Stegall · Mayo Clinic Rochester · U01 · FY2012 · AI
Advanced Genotypic and Phenotypic monitoring of Drug Resistant TB to Improve TB Treatment Outcomes
$846,347Michelle H Larsen · Albert Einstein College Of Medicine · R01 · FY2025 · AI
CDK8/19 inhibitors for therapy of advanced prostate cancer
$846,340Mengqian Chen · Senex Biotechnology, Inc. · R44 · FY2021 · CA
Multi-omics approach to frailty resilience
$846,303Sofiya Milman · Albert Einstein College Of Medicine · R56 · FY2021 · AG
Novel AAVs engineered for efficient and noninvasive cross-species gene editing throughout the central nervous system
$846,261Benjamin E Deverman · Broad Institute, Inc. · UG3 · FY2018 · NS
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.
$846,223Sunnie Yoh · Scripps Research Institute, The · R01 · FY2025 · AI